Search results
Results from the WOW.Com Content Network
According to the Center for Public Integrity, from January 2005 through June 2006 alone, the pharmaceutical industry spent approximately $182 million on federal lobbying in the United States. [2] In 2005, the industry had 1,274 registered lobbyists in Washington, D.C. [ 3 ]
In the 1990s, the US medical biological defense research effort (part of the U.S. Army's Biological Defense Research Program [BDRP]) was concentrated at USAMRIID at Fort Detrick. The army maintained state-of-the-art containment laboratory facilities there, with more than 10,000 ft2 of BSL-4 and 50,000 ft2 of BSL-3 laboratory space.
United States Army Materiel Command (AMC) Army Research, Development and Engineering Command (RDECOM) Army Research Laboratory (ARL) Army Armament Research, Development and Engineering Center (ARDEC) Engineer Research and Development Center (ERDC) U.S. Army Test and Evaluation Command (ATEC) Army Medical Research and Material Command (USAMRMC)
The Strategic National Stockpile (SNS), originally called the National Pharmaceutical Stockpile (NPS), is the United States' national repository of antibiotics, vaccines, chemical antidotes, antitoxins, and other critical medical supplies.
Full public disclosure of lobbying activity Requires lobbyist disclosure filings to be filed twice as often, by decreasing the time between filing from semi-annual to quarterly. Requires lobbyist disclosures in both the Senate and House to be filed electronically and requires creation of a public searchable Internet database of such information.
It will also join a lawsuit filed by Merck and industry lobbying firm PhRMA, officials said Thursday. The filing due date for the briefs are Sept. 18 for the Merck lawsuit and Oct. 6 for PhRMA.
Founded in 1958, PhRMA lobbies on behalf of pharmaceutical companies. [ 2 ] [ 3 ] PhRMA is headquartered in Washington, D.C. [ 1 ] The organization has lobbied fiercely against allowing Medicare to negotiate drug prices for Medicare recipients, [ 4 ] and filed lawsuits against the drug price provisions in the Inflation Reduction Act . [ 5 ]
“You got all these people with this disease who need treatment,” he said. “There’s a medication that could really help us tackle this problem, help us dramatically reduce overdose death, and people are having a hard time accessing it.” The anti-medication approach adopted by the U.S. sets it apart from the rest of the developed world.